Moreover, like in breast, endometrial and ovarian cancer, ERα protein is increased, ERβ protein is decreased and finally the ERα/ERβ protein ratio is upregulated, which is involved in the occurrence and development of PTC21–24. This evidence concerns the gene ESR1 and ovarian cancer.